A clinical study to assess the safety and immune response of rabies vaccine of Serum Institute of India Ltd (SIIL).
Phase 1
Completed
- Registration Number
- CTRI/2011/07/001903
- Lead Sponsor
- Serum Institute of India Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Willing to give informed consent and whose clinical laboratory examinations are within the clinically acceptable normal range.
Exclusion Criteria
1. Subjects participating in any other clinical trial, 2. previous history of Rabies. 3. received rabies immunoglobulin 4. febrile illness. 5. Known systemic hypersensitivity to vaccine components 6. pregnancy or positive urine pregnancy test. 7. Breast-feeding 8. thrombocytopenia 8. subject at high risk for rabies exposure during the trial period. 9. concomitant antimalarial drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method